Skip to main content

CHARLES SCHWAB INVESTMENT MANAGEMENT INC

Position in SYRE — Spyre Therapeutics, Inc.

CIK 884546 SAN FRANCISCO, CA

Position in SYRE

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$28,380,217
+$9,555,601 QoQ
Shares Held
562,653
-2.1% QoQ
Ownership
0.648%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2024
9 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SYRE Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $6,185,699,337 across 288 Biotechnology names. SYRE ranks #46 (0.5% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in SYRE

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $28,380,217 562,653
2025-12-31 $18,824,616 574,622
2025-09-30 $7,128,782 425,345
2025-06-30 $6,264,989 418,503
2025-03-31 $6,173,831 382,636
2024-12-31 $8,838,252 379,650
2024-09-30 $9,801,617 333,275
2024-06-30 $2,308,235 98,181
2024-03-31 $568,950 15,000